Novo Nordisk (spons. ADRs) Aktie

Kaufen

Verkaufen

Aktien-Sparplan anlegen Aktien-Sparplan anlegen

41,00 EUR -0,75 EUR -1,80 %

19.02.2026

BMN

48,38 USD -0,08 USD -0,15 %

nachbörslich19.02.2026

BTT

Novo Nordisk (spons. ADRs) jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

Bei einem anderen Broker handeln

Smartphone

KGV14,59Div. Rendite2,61%

WKN866931

ISINUS6701002056

SymbolNVO

Novo Nordisk (spons. ADRs) Aktien News

Sortieren:Datum Meistgelesen

19.02.26MotleyFoolOverlooked and Undervalued: Why Novo Nordisk Stock Deserves Attention

12.02.26BenzingaNovo Nordisk Plans Wegovy Vial Launch To Counter Eli Lilly, Target Broader Obesity Market

12.02.26MotleyFoolEli Lilly vs Novo Nordisk in the Weight Loss Drug Market: Here's What Investors Need to Know.

WerbungNovo Nordisk (spons. ADRs)-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

12.02.26BenzingaNovo Nordisk CEO Sees Opportunity For 15 Million New Patients As Medicare Covers Obesity Drugs

10.02.26ZacksHere is What to Know Beyond Why Novo Nordisk A/S (NVO) is a Trending Stock

10.02.26ZacksNovo Nordisk Rallies 3.6% as Hims & Hers Pulls Compounded Semaglutide

10.02.26Financial TimesNovo Nordisk hits back at copycat drugs

09.02.26MotleyFoolStock Market Today, Feb. 9: Hims & Hers Health Drops 16% on Novo Nordisk Lawsuit

09.02.26MotleyFoolNovo Nordisk vs. Eli Lilly: What's the Better Long-Term Investment?

09.02.26MotleyFoolWhy Novo Nordisk Stock Just Popped

09.02.26RTE.ieNovo Nordisk sues Hims after $49 weight-loss pill drama

09.02.26ZacksNovo Nordisk Stock Whipsawed by GLP-1 Pill Fears: Relief Ahead?

09.02.26BenzingaNovo Nordisk Takes Legal Action Against Hims & Hers Over Wegovy Knock Offs

09.02.26Financial TimesNovo Nordisk sues Hims & Hers over copycat weight-loss drugs

09.02.26Financial TimesNovo Nordisk faces more gloom from price cuts in crowded anti-obesity drugs market

08.02.26MotleyFoolNovo Nordisk Plunges Nearly 15% After Earnings. Here's What Investors Need to Know.

08.02.26BenzingaGartner, Stellantis, And Novo Nordisk Are Among Top 10 Large Cap Losers Last Week (Feb. 2-Feb. 6): Are the Others in Your Portfolio?

06.02.26MotleyFoolEli Lilly vs Novo Nordisk: The 1 Figure Investors Shouldn't Ignore

06.02.26BenzingaWhat's Going On With Novo Nordisk Stock On Friday?

06.02.26MotleyFoolWhy Shares of Novo Nordisk Stock Collapsed This Week

06.02.26MotleyFoolWhy Did AMD, Uber, and Novo Nordisk Stock Crash This Week?

06.02.26MarketWatchNovo Nordisk stock climbs out of hole on FDA chief’s threat to block Hims and Hers pill

05.02.26MotleyFoolHims & Hers Takes On Novo Nordisk: What We Know Right Now

05.02.26BenzingaHims & Hers Launches Compounded Version Of Wegovy, Novo Nordisk Threatens Legal Action

05.02.26MotleyFoolThis Healthcare Company Believes Its GLP-1 Pill Could Be "Next in Line" After Novo Nordisk and Eli Lilly. Its Valuation Is a Fraction of Theirs.

05.02.26Financial TimesNovo Nordisk hits out at rival Hims & Hers over cheaper weight-loss pill

05.02.26MotleyFoolCan Pfizer Crash the Lilly and Novo Nordisk Weight-Loss Party?

04.02.26MotleyFoolNovo Nordisk Plunges After Releasing a Brutal Forecast. Should You Dump the Stock?

04.02.26BenzingaIn Weight Loss Drug Battle For 2026, Eli Lilly Pulls Ahead Of Novo Nordisk

04.02.26Financial TimesNovo Nordisk is the biggest loser in the weight-loss duopoly

04.02.26ZacksHealthcare ETFs to Watch as Novo Nordisk Tumbles on Poor Sales Outlook

04.02.26New York TimesNovo Nordisk Warns of First Sales Drop Since Start of Ozempic

04.02.26BenzingaOzempic Maker Novo Nordisk Flags Declining Sales In 2026

04.02.26MarketWatchNovo Nordisk CEO tells investors to expect weight-loss drug pricing to go down before it comes back up

04.02.26BenzingaSuper Micro Computer, Chipotle Mexican Grill, PayPal, Novo Nordisk And AMD: Why These 5 Stocks Are On Investors' Radars Today

04.02.26MotleyFoolStock Market Today, Feb. 3: Novo Nordisk Slides as Pricing Pressure Clouds Obesity-Drug Outlook

03.02.26BenzingaNovo Nordisk Stock Falls As 2026 Outlook Signals Pricing Pressure, Slowing Sales

03.02.26Financial TimesNovo Nordisk’s shares tumble after sales warning as gap widens with Eli Lilly

02.02.26MotleyFoolIs Novo Nordisk Stock a Bargain Right Now?

02.02.26ZacksBeat the Market the Zacks Way: Five Below, Novo Nordisk, Ekso in Focus

Novo Nordisk (spons. ADRs) News

Novo Nordisk (spons. ADRs) News: auf dieser Seite finden Sie alle Novo Nordisk (spons. ADRs) News und Nachrichten zur Novo Nordisk (spons. ADRs) Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Novo Nordisk (spons. ADRs) News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Novo Nordisk (spons. ADRs) News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.